The temporal kinetics of circulating angiopoietin levels in children with sepsis

Pediatric Critical Care Medicine

Volumn 15, Issue 1, 2014, Pages

  Giuliano, John S ^a   Tran, Kevin ^a   Li, Fang Yong ^a   Shabanova, Veronika ^a   Tala, Joana A ^b   Bhandari, Vineet ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN CHILDREN S HOSPITAL   (United States)

Author keywords

Capillary leak; Intensive care; Pediatric; Shock

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2;

ADOLESCENT; ARTICLE; BODY WEIGHT; CHILD; COMORBIDITY; CRITICALLY ILL PATIENT; DISEASE DURATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUID INTAKE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TERTIARY HEALTH CARE;

ADOLESCENT; ANGIOPOIETIN-1; ANGIOPOIETIN-2; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INTENSIVE CARE UNITS, PEDIATRIC; LENGTH OF STAY; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS;

EID: 84892798419     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3182a553bb     Document Type: Article

References (38)

1. Kochanek KD, Kirmeyer SE, Martin J.A., et al.: Annual summary of vital statistics: 2009. Pediatrics 2012; 129:338-348
2. Watson RS, Carcillo JA: Scope and epidemiology of pediatric sepsis. Pediatr Crit Care Med 2005; 6:S3-S5
3. Watson RS, Carcillo JA, Linde-Zwirble WT, et al.: The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003; 167:695-701
4. Lagu T, Rothberg MB, Shieh M.S., et al.: Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med 2012; 40:754-761
5. Proulx F, Joyal JS, Mariscalco M.M., et al.: The pediatric multiple organ dysfunction syndrome. Pediatr Crit Care Med 2009; 10:12-22
6. Aird WC: The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003; 101:3765-3777
7. Brindle N.P., Saharinen P, Alitalo K: Signaling and functions of angio-poietin-1 in vascular protection. Circ Res 2006; 98:1014-1023
8. Fiedler U, Augustin HG: Angiopoietins: A link between angiogenesis and inflammation. Trends Immunol 2006; 27:552-558
9. Maisonpierre PC, Suri C, Jones P.F., et al.: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277:55-60
10. van Meurs M., Kümpers P, Ligtenberg J.J., et al.: Bench-to-bedside review: Angiopoietin signalling in critical illness - A future target? Crit Care 2009; 13:207
11. Giuliano JS J.r., Lahni PM, Bigham M.T., et al.: Plasma angiopoietin-2 levels increase in children following cardiopulmonary bypass. Intensive Care Med 2008; 34:1851-1857
12. Ng MT, Stammers AT, Kwon BK: Vascular disruption and the role of angiogenic proteins after spinal cord injury. Transl Stroke Res 2011; 2:474-491
13. Giamarellos-Bourboulis E.J., Kanellakopoulou K, Pelekanou A., et al.: Kinetics of angiopoietin-2 in serum of multi-trauma patients: Correlation with patient severity. Cytokine 2008; 44:310-313
14. Ganter MT, Cohen MJ, Brohi K, et al.: Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma? Ann Surg 2008; 247:320-326
15. Calfee CS, Gallagher D, Abbott J., et al.: Plasma angiopoietin-2 in clinical acute lung injury: Prognostic and pathogenetic significance. Crit Care Med 2012; 40:1731-1737
16. Ong T, McClintock DE, Kallet R.H., et al.: Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients. Crit Care Med 2010; 38:1845-1851
17. Gallagher DC, Parikh SM, Balonov K, et al.: Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome. Shock 2008; 29:656-661
18. van der Heijden M, van Nieuw Amerongen GP, Koolwijk P, et al.: Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ ARDS in septic and non-septic critically ill patients. Thorax 2008; 63:903-909
19. Parikh SM, Mammoto T, Schultz A., et al.: Excess circulating angiopoi-etin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006; 3:e46
20. Conroy AL, Glover SJ, Hawkes M, et al.: Angiopoietin-2 levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria: A retrospective case-control study. Crit Care Med 2012; 40:952-959
21. Ricciuto DR, dos Santos CC, Hawkes M, et al.: Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med 2011; 39:702-710
22. Kümpers P., Hafer C, David S., et al.: Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: Relation to acute kidney injury, multiple organ dysfunction syndrome and outcome. Intensive Care Med 2010; 36:462-470
23. Siner JM, Bhandari V, Engle K.M., et al.: Elevated serum angiopoietin 2 levels are associated with increased mortality in sepsis. Shock 2009; 31:348-353
24. van der Heijden M, Pickkers P, van Nieuw Amerongen G P, et al.: Circulating angiopoietin-2 levels in the course of septic shock: Relation with fluid balance, pulmonary dysfunction and mortality. Intensive Care Med 2009; 35:1567-1574
25. Kümpers P., Lukasz A, David S., et al.: Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 2008; 12:R147
26. Giuliano JS J.r., Lahni PM, Harmon K, et al.: Admission angiopoietin levels in children with septic shock. Shock 2007; 28:650-654
27. Orfanos SE, Kotanidou A, Glynos C., et al.: Angiopoietin-2 is increased in severe sepsis: Correlation with inflammatory mediators. Crit Care Med 2007; 35:199-206
28. David S, Mukherjee A, Ghosh C.C., et al.: Angiopoietin-2 may contribute to multiple organ dysfunction and death in sepsis. Crit Care Med 2012; 40:3034-3041
29. Mankhambo LA, Banda DL, Jeffers G, et al.; IPD Study Group: The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children. Crit Care 2010; 14:R91
30. Aghai ZH, Faqiri S, Saslow J.G., et al.: Angiopoietin 2 concentrations in infants developing bronchopulmonary dysplasia: Attenuation by dexa-methasone. J Perinatol 2008; 28:149-155
31. Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis: International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6:2-8
32. Slater A, Shann F, Pearson G; Paediatric Index of Mortality (PIM) Study Group: PIM2: A revised version of the Paediatric Index of Mortality. Intensive Care Med 2003; 29:278-285
33. Leteurtre S, Martinot A, Duhamel A., et al.: Validation of the paediat-ric logistic organ dysfunction (PELOD) score: Prospective, observational, multicentre study. Lancet 2003; 362:192-197
34. Leteurtre S, Duhamel A, Grandbastien B., et al.: Paediatric logistic organ dysfunction (PELOD) score. Lancet 2006; 367:897; author reply 900-902
35. Fiedler U, Scharpfenecker M, Koidl S., et al.: The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004; 103: 4150-4156
36. Gamble JR, Drew J, Trezise L., et al.: Angiopoietin-1 is an antiperme-ability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 2000; 87:603-607
37. van der Heijden M, van Nieuw Amerongen G P, van Bezu J, et al.: Opposing effects of the angiopoietins on the thrombin-induced permeability of human pulmonary microvascular endothelial cells. PLoS One 2011; 6:e23448
38. Marshall JC: Sepsis: Rethinking the approach to clinical research. J Leukoc Biol 2008; 83:471-482